Literature DB >> 11938457

Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.

M R Mautino1, R A Morgan.   

Abstract

Retroviral vectors expressing transdominant negative mutants of Rev (TdRev) inhibit HIV-1 replication by preventing the nuclear export of unspliced viral transcripts, thus inhibiting the synthesis of Gag-Pol, Env and reducing the levels of genomic RNA available for packaging. Due to these effective mechanisms of inhibition, production of HIV-1-based lentiviral vectors expressing TdRev has been difficult. Here we describe HIV-based vectors in which expression of TdRev is negatively regulated by Rev expression. In these vectors, we maintained the wild-type HIV-1 Tat/Rev exons and intron configuration and its mode of splicing regulation. The second Rev exon was mutated to encode TdRev. Inhibition of TdRev expression by Rev during vector production yields high titer vector preparations. A second vector containing an additional anti-HIV gene (env-antisense) was constructed by flipping a 1.2-kb env fragment contained within the Tat/TdRev intron. SupT1 cells and primary CD4+ lymphocytes transduced with these vectors inhibit HIV-1 replication and show a preferential advantage for survival. Although these vectors are poorly mobilized to secondary target cells by wild-type HIV-1, they reduce the infectivity of the wild-type virions escaping inhibition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11938457     DOI: 10.1038/sj.gt.3301674

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  6 in total

1.  Efficient transduction of cytotoxic and anti-HIV-1 genes by a gene-regulatable lentiviral vector.

Authors:  Yasuhiko Shinoda; Kuniko Hieda; Yoshio Koyanagi; Youichi Suzuki
Journal:  Virus Genes       Date:  2009-10       Impact factor: 2.332

2.  Bcl-2 overexpression enhances tumor-specific T-cell survival.

Authors:  Jehad Charo; Steven E Finkelstein; Navrose Grewal; Nicholas P Restifo; Paul F Robbins; Steven A Rosenberg
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

3.  Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance.

Authors:  Xiaobin Lu; Qiao Yu; Gwendolyn K Binder; Ziping Chen; Tatiana Slepushkina; John Rossi; Boro Dropulic
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection.

Authors:  Leor S Weinberger; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 5.  Genetic therapies against HIV.

Authors:  John J Rossi; Carl H June; Donald B Kohn
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

6.  RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release.

Authors:  Claudia S López; Rachel Sloan; Isabel Cylinder; Susan L Kozak; David Kabat; Eric Barklis
Journal:  Virology       Date:  2014-06-25       Impact factor: 3.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.